AU759557B2 - Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood - Google Patents

Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood Download PDF

Info

Publication number
AU759557B2
AU759557B2 AU14184/99A AU1418499A AU759557B2 AU 759557 B2 AU759557 B2 AU 759557B2 AU 14184/99 A AU14184/99 A AU 14184/99A AU 1418499 A AU1418499 A AU 1418499A AU 759557 B2 AU759557 B2 AU 759557B2
Authority
AU
Australia
Prior art keywords
formula
perfluorocarbon
accordance
liquid
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU14184/99A
Other languages
English (en)
Other versions
AU1418499A (en
Inventor
Leland C. Clark
Richard E. Hoffmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tenax Therapeutics Inc
Original Assignee
Synthetic Blood International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthetic Blood International Inc filed Critical Synthetic Blood International Inc
Publication of AU1418499A publication Critical patent/AU1418499A/en
Application granted granted Critical
Publication of AU759557B2 publication Critical patent/AU759557B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU14184/99A 1997-11-20 1998-11-18 Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood Expired AU759557B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/975743 1997-11-20
US08/975,743 US6167887B1 (en) 1997-11-21 1997-11-21 Selected C-10 perfluorinated hydrocarbons for liquid ventilation and artificial blood
PCT/US1998/024632 WO1999026604A2 (en) 1997-11-20 1998-11-18 Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood

Publications (2)

Publication Number Publication Date
AU1418499A AU1418499A (en) 1999-06-15
AU759557B2 true AU759557B2 (en) 2003-04-17

Family

ID=25523336

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14184/99A Expired AU759557B2 (en) 1997-11-20 1998-11-18 Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood

Country Status (6)

Country Link
US (1) US6167887B1 (enExample)
EP (1) EP1037619A4 (enExample)
JP (1) JP2003522094A (enExample)
AU (1) AU759557B2 (enExample)
CA (1) CA2311122C (enExample)
WO (1) WO1999026604A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2007081008A1 (ja) * 2006-01-16 2009-06-11 旭硝子株式会社 新規なフッ素系界面活性剤および新規な含フッ素化合物
CN101443272A (zh) * 2006-05-15 2009-05-27 弗吉尼亚联邦大学 用于受控和持续产生并输送过氧化物的方法和组合物
EP2198869B1 (en) 2007-02-23 2015-09-16 Next 21 K.K. Trehalose for the treatment or prevention of vasospasm
EP2252333A4 (en) * 2008-02-13 2013-07-10 Oxygen Biotherapeutics Inc WOUND AND TISSUE THERAPY ON GAS BASIS
US8404752B2 (en) * 2008-07-18 2013-03-26 Oxygen Biotherapeutics, Inc. Method of treating traumatic brain injury
US8343515B2 (en) 2008-11-25 2013-01-01 Oxygen Biotherapeutics, Inc. Perfluorocarbon gel formulations
KR20110096054A (ko) * 2008-11-25 2011-08-26 옥시젠 바이오테라퓨틱스 인코포레이티드 과불화탄소 겔 배합물
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
WO2011014247A1 (en) * 2009-07-28 2011-02-03 Oxygen Biotherapeutics, Inc. Method to increase oxygen in male and female sexual organs through the topical use of perfluorocarbons
CN102497888B (zh) * 2009-07-31 2014-10-29 皇家飞利浦电子股份有限公司 用于成像的全氟化合物
EP2547201A1 (en) * 2010-03-19 2013-01-23 Oxygen Biotherapeutics, Inc. Perfluorocarbon eye cream formulations
WO2012044963A2 (en) 2010-10-01 2012-04-05 Oxygen Biotherapeutics, Inc. Perfluorocarbons for use in treating pruritus

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911138B1 (en) 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
US4453028A (en) 1982-03-29 1984-06-05 Lagow Richard J Perfluorinated compounds with cyclohexyl groups
US4443480A (en) * 1982-04-12 1984-04-17 Children's Hospital Medical Center Artificial blood and other gas transport agents
USRE33451E (en) 1982-04-12 1990-11-20 Children's Hospital Medical Center Artificial blood and other gas transport agents
US4686024A (en) 1985-02-01 1987-08-11 The Green Cross Corporation Novel perfluoro chemicals and polyfluorinated compounds and process for production of the same
US5437272A (en) 1991-05-01 1995-08-01 Alliance Pharmaceutical Corp. Perfluorocarbon associated gas exchange
EP0583358B1 (en) 1991-05-03 1998-12-02 Alliance Pharmaceutical Corporation Partial liquid breathing of fluorocarbons
US5146014A (en) * 1991-07-02 1992-09-08 Air Products And Chemicals, Inc. Perfluoroethyldimethyl cyclohexane
US5674913A (en) 1994-05-13 1997-10-07 Synthetic Blood International, Inc. Method for assisting normal breathing in a mammal having a lung disorder
US5840767A (en) 1995-12-01 1998-11-24 Synthetic Blood International, Inc. Perfluorocarbons for biological gas exchange and method
JP4289499B2 (ja) * 2004-09-06 2009-07-01 城南鋼鉄工業株式会社 扉のロック機構

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MOORE ET AL OXYGEN CARRYING COLLOIDAL BLOOD SUBSTITUTES 5TH INT.SYMP ON PERFLUOROCARBON BLOOD SUBSTITUTES, MAINZ, MARCH 1981, PGS.51-60 *

Also Published As

Publication number Publication date
US6167887B1 (en) 2001-01-02
JP2003522094A (ja) 2003-07-22
CA2311122C (en) 2004-04-13
EP1037619A4 (en) 2001-08-13
AU1418499A (en) 1999-06-15
EP1037619A2 (en) 2000-09-27
CA2311122A1 (en) 1999-06-03
WO1999026604A2 (en) 1999-06-03
WO1999026604A3 (en) 1999-10-14

Similar Documents

Publication Publication Date Title
CA1042799A (en) Perfluorocyclocarbons as gas transport agents in animals
Jones Desflurane and sevoflurane: inhalation anaesthetics for this decade?
US6167887B1 (en) Selected C-10 perfluorinated hydrocarbons for liquid ventilation and artificial blood
JP6916542B2 (ja) 麻酔を誘発する方法
Aitkenhead et al. Textbook of anaesthesia
US4443480A (en) Artificial blood and other gas transport agents
Shaffer et al. Liquid ventilation in premature lambs: uptake, biodistribution and elimination of perfluorodecalin liquid
AU597781B2 (en) Anesthetic composition and method of using the same
Clark Jr et al. Ring versus straight chain perfluorocarbon emulsions for perfusion media
Modell et al. Liquid ventilation of primates
EP0758886B1 (en) Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders
Hudson et al. Pharmacokinetics of inhaled anesthetics
Pihlainen et al. Analytical toxicology of fluorinated inhalation anaesthetics
Koblin et al. Polyhalogenated methyl ethyl ethers: solubilities and anesthetic properties
Tsatsakis et al. Fatal and non-fatal outcome by accidental intoxication with paint thinner
Rosales et al. Sevoflurane Concentrations in Blood, Brain, and Lung After Sevoflurane‐Induced Death
Levine et al. A fatality from sevoflurane abuse
THOMASON et al. Methoxyflurane anesthesia: a clinical appraisal
Thomas et al. Effect of hemodialysis on plasma cholinesterase
FABIAN et al. Laboratory and clinical investigation of some newly synthesized fluorocarbon anesthetics
Rae Theory versus practice in the Twentieth-Century search for the ideal anaesthetic gas
Monticelli et al. Another case of diethyl ether intoxication? A case report focusing on toxicological analysis
Aljerf et al. Halothane Anesthesia–Fact or Fallacy
Kalman et al. Minimum alveolar concentration of halothanediethyl‐ether azeotrope
Yang et al. Effects of grade B liver dysfunction on the level of free hexafluoroisopropanol of sevoflurane metabolites in patients with abdominal surgery

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired